Biology of Blood and Marrow Transplantation
Volume 13, Issue 12 , Pages 1455-1460 , December 2007

HLA-Matched Related Donor Hematopoietic Cell Transplantation in 43 Patients with Fanconi Anemia Conditioned with 60 mg/kg of Cyclophosphamide

  • Carmem M. Bonfim

      Affiliations

    • Bone Marrow Transplantation Service, Federal University of Parana, Curitiba, PR, Brazil
    • These authors contributed equally to the work.
    • ,
  • Carlos R. de Medeiros

      Affiliations

    • Bone Marrow Transplantation Service, Federal University of Parana, Curitiba, PR, Brazil
    • These authors contributed equally to the work.
    • ,
  • Marco A. Bitencourt

      Affiliations

    • Bone Marrow Transplantation Service, Federal University of Parana, Curitiba, PR, Brazil
    • ,
  • José Zanis-Neto

      Affiliations

    • Bone Marrow Transplantation Service, Federal University of Parana, Curitiba, PR, Brazil
    • ,
  • Vaneuza A.M. Funke

      Affiliations

    • Bone Marrow Transplantation Service, Federal University of Parana, Curitiba, PR, Brazil
    • ,
  • Daniela C. Setubal

      Affiliations

    • Bone Marrow Transplantation Service, Federal University of Parana, Curitiba, PR, Brazil
    • ,
  • Jefferson Ruiz

      Affiliations

    • Bone Marrow Transplantation Service, Federal University of Parana, Curitiba, PR, Brazil
    • ,
  • Jean E. Sanders

      Affiliations

    • Division of Clinical Research, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington
    • ,
  • Mary E.D. Flowers

      Affiliations

    • Division of Clinical Research, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington
    • ,
  • Hans-Peter Kiem

      Affiliations

    • Division of Clinical Research, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington
    • ,
  • Rainer Storb

      Affiliations

    • Division of Clinical Research, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington
    • Corresponding Author InformationCorrespondence and reprint requests: Rainer Storb, MD, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, PO Box 19024, Seattle, WA, 98109-1024.
    • ,
  • Ricardo Pasquini

      Affiliations

    • Bone Marrow Transplantation Service, Federal University of Parana, Curitiba, PR, Brazil

Received 9 July 2007 ,Accepted 9 August 2007.

References 

  1. Young NS, Alter BP. Clinical features of Fanconi’s anemia. In: Aplastic Anemia, Acquired and Inherited. Philadelphia: W.B. Saunders Co; 1994;p. 275–309
  2. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Fanconi anemia. Blood. 1995;86:2856–2862
  3. Flowers MED, Zanis J, Pasquini R, et al. Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol. 1996;92:699–706
  4. Zanis-Neto J, Ribeiro RC, Medeiros C, et al. Bone marrow transplantation for patients with Fanconi anemia: a study of 24 cases from a single institution. Bone Marrow Transplant. 1995;15:293–298
  5. Medeiros C, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant. 1999;24:849–852
  6. Zanis-Neto J, Flowers MED, Medeiros CR, et al. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anemia. Br J Haematol. 2005;130:99–106
  7. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304
  8. Lee SJ, Vogelsang G, Flowers MED. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9:215–233
  9. Santos GW, Owens AH. Allogeneic marrow transplants in cyclophosphamide treated mice. Transplant Proc. 1969;1:44–46
  10. Storb R, Epstein RB, Rudolph RH, Thomas ED. Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation. 1969;7:378–386
  11. Storb R, Buckner CD, Dillingham LA, Thomas ED. Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion. Cancer Res. 1970;30:2195–2203
  12. Deeg HJ, Storb R, Prentice R, et al. Increased cancer risk in canine radiation chimeras. Blood. 1980;55:233–239
  13. Witherspoon RP, Storb R, Pepe M, Longton G, Sullivan KM. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone. Blood. 1992;79:289–292(Letter)
  14. Deeg HJ, Socié G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386–392
  15. Storb R, Thomas ED, Buckner CD, et al. Allogeneic marrow grafting for treatment of aplastic anemia. Blood. 1974;43:157–180
  16. Gluckman E, Devergie A, Schaison G, et al. Bone marrow transplantation for Fanconi anaemia. Br J Haematol. 1980;45:557–564
  17. Deeg HJ, Storb R, Thomas ED, et al. Fanconi’s anemia treated by allogeneic marrow transplantation. Blood. 1983;61:954–959
  18. Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplastic anemia (An analysis of factors associated with graft rejection). N Engl J Med. 1977;296:61–66
  19. Farzin A, Davies SM, Smith FO, et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children’s experience. Br J Haematol. 2007;136:633–640
  20. Bitan M, Or R, Shapira MY, et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant. 2006;12:712–718
  21. Wagner JE, Eapen M, MacMillan ML, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood. 2007;109:2256–2262
  22. Guardiola P, Socie G, Li X, et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood. 2004;103:73–77
  23. Ayas M, Al-Jefri A, Al-Mahr M, et al. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophospha-mide and antithymocyte globulins withour the use of radiation therapy. Bone Marrow Transplant. 2005;35:463–466
  24. Rosenberg PS, Alter BP, Socie G, Gluckman E. Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies. Biol Blood Marrow Transplant. 2005;11:672–679
  25. Nash RA, Pepe MS, Storb R, et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood. 1992;80:1838–1845
  26. Storb R, Prentice RL, Sullivan KM, et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med. 1983;98:461–466
  27. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105:67–73

PII: S1083-8791(07)00382-5

doi: 10.1016/j.bbmt.2007.08.004

Biology of Blood and Marrow Transplantation
Volume 13, Issue 12 , Pages 1455-1460 , December 2007

Article Tools

* Image Usage & Resolution